Long-term virologic and immunologic responses on darunavir/ritonavir - containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil

Vidal, José E; Santos, Ariane M R dos; Miranda, Érique J F Peixoto de; Segurado, Aluísio C

Vidal, José E; Santos, Ariane M R dos; Miranda, Érique J F Peixoto de; Segurado, Aluísio C.

Vidal, José E; Universidade de São Paulo. São Paulo. BR
Santos, Ariane M R dos; Universidade de São Paulo. São Paulo. BR
Miranda, Érique J F Peixoto de; Universidade de São Paulo. São Paulo. BR
Segurado, Aluísio C; Universidade de São Paulo. São Paulo. BR

Braz. j. infect. dis ; 21(6): 680-681, Nov.-Dec. 2017. graf

Article in English | LILACS | ID: biblio-888920

Subject(s)

Humans; HIV Infections/drug therapy; HIV Protease Inhibitors/therapeutic use; Ritonavir/therapeutic use; Darunavir/therapeutic use; Brazil; HIV Infections/immunology; HIV Infections/virology; Prospective Studies; Follow-Up Studies; Salvage Therapy; CD4 Lymphocyte Count

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / HIV Protease Inhibitors / Ritonavir / Darunavir Type of study: Etiology study / Observational study / Prognostic study Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google